State Street
EWTX icon

State Street’s Edgewise Therapeutics EWTX Stock Holding History

State Street’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.3M Buy
1,827,927
+111,104
+6% +$3.83M ﹤0.01% 1645
2026
Q1 		$54.1M Sell
1,716,823
-520
-0% -$15K ﹤0.01% 1700
2025
Q4 		$42.6M Buy
1,717,343
+17,434
+1% +$350K ﹤0.01% 1826
2025
Q3 		$27.6M Sell
1,699,909
-81,592
-5% -$1.16M ﹤0.01% 2070
2025
Q2 		$23.4M Buy
1,781,501
+63,777
+4% +$920K ﹤0.01% 2106
2025
Q1 		$37.8M Buy
1,717,724
+2,179
+0.1% +$57.2K ﹤0.01% 1792
2024
Q4 		$45.8M Buy
1,715,545
+30,430
+2% +$969K ﹤0.01% 1757
2024
Q3 		$45M Buy
1,685,115
+20,020
+1% +$398K ﹤0.01% 1758
2024
Q2 		$30M Buy
1,665,095
+453,619
+37% +$7.91M ﹤0.01% 1932
2024
Q1 		$22.1M Buy
1,211,476
+318,767
+36% +$5.07M ﹤0.01% 2151
2023
Q4 		$9.77M Buy
892,709
+104,449
+13% +$733K ﹤0.01% 2608
2023
Q3 		$4.52M Buy
788,260
+39,888
+5% +$271K ﹤0.01% 2968
2023
Q2 		$5.8M Buy
748,372
+89,749
+14% +$757K ﹤0.01% 2928
2023
Q1 		$4.39M Buy
658,623
+59,103
+10% +$548K ﹤0.01% 3043
2022
Q4 		$5.36M Buy
599,520
+37,194
+7% +$349K ﹤0.01% 3012
2022
Q3 		$5.53M Buy
562,326
+37,602
+7% +$380K ﹤0.01% 3008
2022
Q2 		$4.18M Sell
524,724
-39,486
-7% -$298K ﹤0.01% 3186
2022
Q1 		$5.47M Buy
564,210
+35,572
+7% +$458K ﹤0.01% 3135
2021
Q4 		$8.08M Buy
528,638
+329,542
+166% +$5.93M ﹤0.01% 3023
2021
Q3 		$3.31M Buy
199,096
+21,594
+12% +$391K ﹤0.01% 3445
2021
Q2 		$3.79M Buy
+177,502
New +$4.85M ﹤0.01% 3368

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street's EWTX Position: Q2 2026 in Review

State Street increased its Edgewise Therapeutics (EWTX) stake by 6.5% in Q2 2026, buying an estimated $3.83M and bringing the position to 1,827,927 shares worth $74.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

State Street first reported a position in EWTX in Q2 2021 and has held it in 21 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • State Street held 1,827,927 shares of Edgewise Therapeutics worth $74.3M as of Q2 2026.
  • State Street bought 111,104 Edgewise Therapeutics shares in Q2 2026, an estimated $3.83M.
  • Edgewise Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1645 holding.
  • State Street first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.